| 000 -LEADER |
|---|
| fixed length control field |
03865nam a22004215i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20140310150646.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
100301s2010 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781597454179 |
|
978-1-59745-417-9 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC870-923.2 |
|
|---|
| Classification number |
RC875-899.5 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.6 |
| Edition number |
23 |
| 264 #1 - |
|---|
| -- |
Totowa, NJ : |
| -- |
Humana Press, |
| -- |
2010. |
| 912 ## - |
|---|
| -- |
ZDB-2-SME |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lee, Cheryl T. |
| Relator term |
editor. |
| 245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
Bladder Cancer |
| Medium |
[electronic resource] : |
| Remainder of title |
Diagnosis, Therapeutics, and Management / |
| Statement of responsibility, etc |
edited by Cheryl T. Lee, David P. Wood. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Other physical details |
online resource. |
| 440 1# - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
Current Clinical Urology |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Improving Bladder Cancer Staging -- Approaches to Carcinoma In Situ (CIS) -- Fluorescence Cytoscopy -- Restaging TURBT -- Understaging T2: Limitations of Pelvic Imaging -- MRI Endorectal Coil -- PET Imaging: Advances in the Detection of Locally Advanced and Nodal Disease -- Detection of Extravesical Disease: A Lack of Bladder Cancer Markers -- Identification of Nodal Metastases: The role of Iron Oxide Enhanced MRI -- Presence and Significance of Micrometastases -- Optimizing Treatment of Localized Disease -- Perioperative Intravesical Therapy -- BCG Refractory Disease -- Beyond BCG: Gemcitabine -- Beyond BCG: Taxanes -- Extended Lymph Node Dissection -- Prostate Capsule Sparing Cystectomy -- Preservation of Reproductive Organs in Women -- Nerve Sparing Radical Cystectomy -- Quality of Care Indicators for Radical Cystectomy -- Continent Diversion: QOL of Orthotopic Diversion vs. Ileal Conduit -- Voiding Dysfunction After Orthotopic Diversion -- Overcoming the Stigma of Complications of Continent Cutaneous Diversion -- Locally Advanced / Distant Disease: Multi-Modality Treatment -- Neoadjuvant Chemotherapy: The New Standard -- Adjuvant Chemotherapy in Bladder Cancer: A Good Concept But Where’s the Proof? -- Beyond MVAC: New and Improved Chemotherapeutics -- Next Steps: Translational Research -- The Role of Microarray Technologies in Bladder Cancer Management -- Molecular Pathogenesis of Urothelial Carcinoma and the Development of Novel Therapeutic Strategies -- Tools for Study: National Databanking -- Vaccine Development -- Advances in Gene Therapy for Bladder Cancer. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
In Bladder Cancer: Moving the Field Forward, Cheryl Lee, David Wood, and a panel of leading authorities and researchers provide a comprehensive review of the related literature, while providing insights into the obstacles of improved survival and discuss methods to advance the field of Bladder Cancer care. Their work aims to spur innovative thoughts and approaches to common problems in the management of early stage and advanced disease. The book discusses at length the state of bladder cancer staging and the optimal treatment for localized disease. Additional sections review the applications of existing systemic therapies and look at the infrastructure needed to support translational research efforts. Groundbreaking and authoritative, Bladder Cancer: Moving the Field Forward, is the definitive text on the current state of bladder cancer care and a must have for all urologists and medical oncologists who wish to provide their patients with the most comprehensive care. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Medicine. |
|
|---|
| Topical term or geographic name as entry element |
Urology. |
|
|---|
| Topical term or geographic name as entry element |
Medicine & Public Health. |
|
|---|
| Topical term or geographic name as entry element |
Urology/Andrology. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Wood, David P. |
| Relator term |
editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY |
|---|
| Title |
Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Display text |
Printed edition: |
| International Standard Book Number |
9781588299888 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-1-59745-417-9 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
E-Book |
